60.49
Veracyte Inc (VCYT) 最新ニュース
Enterprise value to revenue forward of Veracyte, Inc. – FWB:12V - TradingView
Price to book forward of Veracyte, Inc. – FWB:12V - TradingView
Enterprise value to EBITDA forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally - Yahoo Finance
Veracyte, Inc. Actuals & Estimates (TRADEGATE:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (MUN:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (DUS:12V) - TradingView
Q1 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q4 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q2 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q3 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Veracyte, Inc. Actuals & Estimates (NASDAQ:VCYT) - TradingView
Veracyte Inc (VCYT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VCYT Forecast — Price Target — Prediction for 2027 - TradingView
12V Forecast — Price Target — Prediction for 2027 - TradingView
Veracyte Inc (VCYT) Shares Surge 3.1% -- What GF Score of 75 Tel - GuruFocus
Veracyte Jumps 7.2% Amid Sector-Wide Rally - AlphaStreet
Veracyte stock hits 52-week high at 55.32 USD - Investing.com
Veracyte stock hits 52-week high at 55.32 USD By Investing.com - Investing.com Canada
Insider Sell Alert: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte director Karin Eastham sells $197,234 in stock By Investing.com - Investing.com Australia
Form 4 Veracyte Inc For: 22 June By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock - Investing.com
Veracyte (VCYT) director logs 3,729-share Rule 10b5-1 stock sale - Stock Titan
VCYT News | VERACYTE INC (NASDAQ:VCYT) - ChartMill
[144] VERACYTE, INC. SEC Filing - Stock Titan
VCYT|Veracyte Inc|Price:53.630|Chg%:2.34 - TradingKey
Veracyte Inc (VCYT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Veracyte Inc (VCYT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Veracyte Inc (VCYT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Veracyte Inc (VCYT) Institutional Confidence - TradingKey
Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Veracyte Inc (VCYT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Veracyte stock hits 52-week high at 50.81 USD By Investing.com - Investing.com South Africa
Is Veracyte Inc (VCYT) Overvalued After 3.5% Rally? GF Value Say - GuruFocus
Veracyte stock hits 52-week high at 50.81 USD - Investing.com
High Growth Momentum Breakout Setup: Veracyte Inc (NASDAQ:VCYT) - ChartMill
Veracyte (VCYT) director Jens Holstein awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Eliav Barr receives 5,272 restricted stock units - Stock Titan
Director at Veracyte (VCYT) receives grant of 5,272 restricted stock units - Stock Titan
Evan Jones of Veracyte (NASDAQ: VCYT) receives 5,272 restricted stock units - Stock Titan
Director at VERACYTE, INC. (VCYT) awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Robert Epstein receives 5,272-share RSU grant - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) director awarded 5,272 RSUs vesting over one year - Stock Titan
Veracyte, Inc. 2023 Equity Incentive Plan Amended – SEC 8-K Filing Details and Company Information - Minichart
Veracyte shareholders endorse board, pay and incentive plans - The Globe and Mail
FMR LLC's Strategic Acquisition of Veracyte Inc Shares - GuruFocus
Veracyte (VCYT) investors back 3.5M-share equity plan increase and elect full board - Stock Titan
Veracyte (NASDAQ:VCYT) Hits New 12-Month HighHere's Why - MarketBeat
Why Veracyte (VCYT) is a top momentum stock for the long term - MSN
Here's why Veracyte (VCYT) is a strong growth stock - MSN
Assessing Veracyte (VCYT) Valuation After New Prosigna Launch And Decipher Prostate Clinical Milestones - Sahm
大文字化:
|
ボリューム (24 時間):